A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors - Concepedia

Concepedia

Publication | Closed Access

A phase 1 and dose-finding study of LY2523355 (litronesib), an Eg5 inhibitor, in Japanese patients with advanced solid tumors

57

Citations

24

References

2014

Year

Hiroshi Wakui, Noboru Yamamoto, Satoru Kitazono, Hidenori Mizugaki, Shinji Nakamichi, Yutaka Fujiwara, Hiroshi Nokihara, Yasuhide Yamada, Kohei Suzuki, Hironori Kanda,

Cancer Chemotherapy and Pharmacology

Japanese PatientsOncologyMedicineEg5 InhibitorPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyPhase 1Cancer ResearchDrug Discovery

References

	Year	Citations

Page 1

Page 1